1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Bioprocess Technology Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Bioprocess Technology Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Growth in biologics and biosimilars
- 5.1.2 Biopharma R&D
5.2 Market Opportunities
- 5.2.1 Demand for personalized medicine
- 5.2.2 Increased investments in biopharma
5.3 Future Trends
- 5.3.1 Automation in bioprocessing
- 5.3.2 Single-use technologies
5.4 Impact of Drivers and Restraints
6. Europe Bioprocess Technology Market Regional Analysis
6.1 Europe Bioprocess Technology Market Overview
6.2 Europe Bioprocess Technology Market Revenue 2021-2028 (US$ Million)
6.3 Europe Bioprocess Technology Market Forecast Analysis
7. Europe Bioprocess Technology Market Analysis – by Type
7.1 Cell Culture Media Bioprocess
- 7.1.1 Overview
- 7.1.2 Cell Culture Media Bioprocess: Europe Bioprocess Technology Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Chromatography Bioprocess
- 7.2.1 Overview
- 7.2.2 Chromatography Bioprocess: Europe Bioprocess Technology Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Consumables & Accessories
- 7.3.1 Overview
- 7.3.2 Consumables & Accessories: Europe Bioprocess Technology Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Bioprocess Technology Market Analysis – by Modality
8.1 Single Use and Multiple Use
- 8.1.1 Overview
- 8.1.2 Single Use and Multiple Use: Europe Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Bioprocess Technology Market Analysis – by End User
9.1 Academic & Medical Institutions
- 9.1.1 Overview
- 9.1.2 Single Use and Multiple Use: Europe Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Biopharmaceutical Companies
- 9.2.1 Overview
- 9.2.2 Single Use and Multiple Use: Europe Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Research Laboratories
- 9.3.1 Overview
- 9.3.2 Single Use and Multiple Use: Europe Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Bioprocess Technology Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Bioprocess Technology Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 10.1.1.1 Europe Bioprocess Technology Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Bioprocess Technology Market Breakdown, by Type
- 10.1.1.1.2 UK: Europe Bioprocess Technology Market Breakdown, by Modality
- 10.1.1.1.3 UK: Europe Bioprocess Technology Market Breakdown, by End User
- 10.1.1.2 Germany:
Europe Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Bioprocess Technology Market Breakdown, by Type
- 10.1.1.2.2 Germany: Europe Bioprocess Technology Market Breakdown, by Modality
- 10.1.1.2.3 Germany: Europe Bioprocess Technology Market Breakdown, by End User
- 10.1.1.3 France:
Europe Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Bioprocess Technology Market Breakdown, by Type
- 10.1.1.3.2 France: Europe Bioprocess Technology Market Breakdown, by Modality
- 10.1.1.3.3 France: Europe Bioprocess Technology Market Breakdown, by End User
- 10.1.1.4 Russia:
Europe Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Bioprocess Technology Market Breakdown, by Type
- 10.1.1.4.2 Russia: Europe Bioprocess Technology Market Breakdown, by Modality
- 10.1.1.4.3 Russia: Europe Bioprocess Technology Market Breakdown, by End User
- 10.1.1.5 Italy:
Europe Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Bioprocess Technology Market Breakdown, by Type
- 10.1.1.5.2 Italy: Europe Bioprocess Technology Market Breakdown, by Modality
- 10.1.1.5.3 Italy: Europe Bioprocess Technology Market Breakdown, by End User
- 10.1.1.6 Rest of Europe:
Europe Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Bioprocess Technology Market Breakdown, by Type
- 10.1.1.6.2 Rest of Europe: Europe Bioprocess Technology Market Breakdown, by Modality
- 10.1.1.6.3 Rest of Europe: Europe Bioprocess Technology Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Bioprocess Technology Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 BioPharma Dynamics Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Corning Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Danaher Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Eppendorf SE
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Lonza Group AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck KGaA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Repligen Corp
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Sartorius AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 STAMM Biotech
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights